Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nose and Nasal Cavity01:24

Nose and Nasal Cavity

11.6K
The nose is composed of an observable exterior segment (external nose) and an internal segment within the skull known as the nasal cavity (internal nose). The external nose, visible on the face, consists of a framework of bone and hyaline cartilage enveloped in skin and muscle and lined with a mucous membrane. This structure is supported by the frontal bone, nasal bones, and maxillary bone and is supplemented by a cartilaginous framework comprising the septal nasal cartilage, lateral nasal...
11.6K
Administering Oxygen by Nasal Cannula01:29

Administering Oxygen by Nasal Cannula

3.1K
Oxygen therapy is critical to patient care, especially for those struggling with respiratory issues. This intervention increases the oxygen concentration in the lungs, enhancing the amount of oxygen transported to the body's tissues. One standard method of delivering supplemental oxygen is through a nasal cannula, a non-invasive device that provides low to medium oxygen concentrations.
Nasal Cannulas
A nasal cannula is a lightweight tube split into two prongs placed in the nostrils,...
3.1K
Oxygen Delivering System I: Nasal Cannula and Face Mask01:26

Oxygen Delivering System I: Nasal Cannula and Face Mask

1.6K
The human body requires oxygen to function, and when the natural process of respiration is hindered, external devices, including the following, are needed to help deliver this vital gas.
Nasal Cannula
A nasal cannula is a lightweight tube split at one end into two prongs and placed in the nostrils. It is typically used to deliver low to medium levels of oxygen.
Suggested flow rate: The suggested flow rate for a nasal cannula typically ranges between 1 and 6 L/min.
Oxygen percentage setting:...
1.6K
What is the Immune System?01:38

What is the Immune System?

127.7K
Overview
127.7K
Allergic Reactions02:06

Allergic Reactions

32.3K
Overview
32.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimised Fermentation Production of Radiolabelled Ochratoxin A by <i>Aspergillus ochraceus</i> with Maximum <sup>14</sup>C in the Pentaketide Moiety for Exploring Its Rat Renal Toxicology.

Toxins·2024
Same author

Notoamide R: A Prominent Diketopiperazine Fermentation Metabolite amongst Others of <i>Aspergillus ochraceus</i> in the Absence of Ochratoxins.

Molecules (Basel, Switzerland)·2023
Same author

Chromatographic Fractionation of <i>Penicillium polonicum</i> Fermentation Metabolites in Search of the Nephrotoxin(s) for Rats.

Life (Basel, Switzerland)·2022
Same author

Renal Apoptosis in the Mycotoxicology of <i>Penicillium polonicum</i> and Ochratoxin A in Rats.

Life (Basel, Switzerland)·2022
Same author

Rat Tumour Histopathology Associated with Experimental Chronic Dietary Exposure to Ochratoxin A in Prediction of the Mycotoxin's Risk for Human Cancers.

Toxins·2021
Same author

Comparative Ergot Alkaloid Elaboration by Selected Plectenchymatic Mycelia of <i>Claviceps purpurea</i> through Sequential Cycles of Axenic Culture and Plant Parasitism.

Biology·2020

Related Experiment Video

Updated: Jan 29, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat

Published on: June 4, 2012

17.6K

Nasal Decolonisation of MRSA.

Peter Mantle1

  • 1Faculty of Natural Sciences, Imperial College London, South Kensington, London SW7 2AZ, UK. p.mantle@imperial.ac.uk.

Antibiotics (Basel, Switzerland)
|February 6, 2019
PubMed
Summary

Urinary monic acid A is a new biomarker for tracking nasal mupirocin use in methicillin-resistant Staphylococcus aureus (MRSA) treatment. Understanding why the biomarker is absent in some patients is crucial for effective MRSA decolonisation and preventing resistance.

Keywords:
MRSAMupirocinmonic acid Apseudomonic acid Aurinary biomarker

More Related Videos

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA

Published on: February 9, 2011

23.6K
Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Published on: September 1, 2023

2.4K

Related Experiment Videos

Last Updated: Jan 29, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat

Published on: June 4, 2012

17.6K
Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA

Published on: February 9, 2011

23.6K
Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Published on: September 1, 2023

2.4K

Area of Science:

  • Clinical chemistry
  • Microbiology
  • Pharmacology

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant healthcare challenge, necessitating effective decolonisation strategies.
  • Intra-nasal mupirocin is a common treatment for MRSA decolonisation, but verifying patient adherence can be difficult.
  • Urinary monic acid A has recently been identified as a potential biomarker for mupirocin exposure.

Purpose of the Study:

  • To evaluate the utility of urinary monic acid A as a biomarker for adherence to intra-nasal mupirocin therapy in MRSA patients.
  • To investigate reasons for the absence of urinary monic acid A in some patients undergoing MRSA decolonisation.
  • To ensure that decolonisation efficacy is not compromised and to prevent the development of mupirocin resistance.

Main Methods:

  • Clinical monitoring of patients undergoing MRSA decolonisation with intra-nasal mupirocin.
  • Quantification of urinary monic acid A levels.
  • Analysis of factors potentially influencing biomarker detection and treatment outcomes.

Main Results:

  • Urinary monic acid A was demonstrated as a clinical biomarker for intra-nasal mupirocin exposure.
  • The absence of this biomarker in certain patients was observed, requiring further investigation.
  • The implications of biomarker absence for treatment efficacy and resistance development were highlighted.

Conclusions:

  • Urinary monic acid A serves as a valuable tool for verifying adherence to mupirocin treatment in MRSA decolonisation.
  • Further research is needed to understand the reasons behind the absence of the biomarker in some individuals.
  • Addressing these gaps is essential for optimizing MRSA treatment strategies and mitigating resistance.